Showing 21 - 40 of 57 results
Cancer patients to benefit from new supply chain
A bright future for nuclear medicine in Australia
The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.
Graduate Profile - Robert Raposio
A desire to give people around the world greater access to the benefits of nuclear medicine is behind Robert Raposio and his research into producing radioisotopes in more efficient, cheaper and sustainable ways.
New nuclear medicine manufacturing facility
ANSTO radiochemist receives national conference award
Australian and New Zealand Society of Nuclear Medicine recognises Nigel Lengkeek
Privacy Policy
Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.
Safeguarding Australia's healthcare sector with a new nuclear medicine facility
ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.
Update on building 23 at ANSTO
The Australian Government recently announced $30 million to design a new world-leading nuclear medicine manufacturing facility at ANSTO’s Lucas Heights campus, and replace and an ageing facility.
Event celebrates 15 years of operation of the OPAL multi-purpose reactor
ANSTO and the Embassy of Argentina in Australia proudly hosted an event commemorating the 15th anniversary of the opening of the Open Pool Australian Lightwater (OPAL) multi-purpose nuclear reactor on 18 October.
Special international nuclear medicine flights help sick Aussie kids
ANSTO completed an international overnight dash for nuclear medicine earlier this week, chartering three planes to get potentially life-saving children’s cancer treatments from Japan to hospitals across Australia.
ANSTO to undertake routine shipment of spent fuel in 2025
Independent report into safety of Building 23 at ANSTO
The final report on the safety of Building 23 by the independent expert review team has been completed.
70 years of scientific excellence has brought significant benefits to Australia
ANSTO is a unique national science organisation that began operating under its predecessor The Australian Atomic Energy Commission (AAEC) 70 years ago.
Independent Report - Safety of Building 23
ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.
New Joint Venture to manufacture GMP theranostic radiopharmaceuticals in Australia
Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.
Constructing the world's newest nuclear medicine manufacturing facility
Principal Technical Consultant Michael Druce shares some personal insights on the design and construction of ANSTO's nuclear medicine facility.
FAQs on the Mo-99 Manufacturing Facility
Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.
Funding supports biomedical research
ANSTO part of consortium funded by Federal Government to develop new radioimmunological drugs.
Community FAQs
Frequently asked questions about ANSTO for the community.